Globomycin from Streptomyces hagronensis,

Code: g1424-1mg D2-231

Not available outside of the UK & Ireland.

Biochem/physiol Actions

Globomycin was found to inhibit LspA, a lipoprotein signal peptidase. It eliminates the maturation of pro-lipoproteins by inhibition of the enzyme tha...


read more

Your Price
$617.70 1MG

Not available outside of the UK & Ireland.

Biochem/physiol Actions

Globomycin was found to inhibit LspA, a lipoprotein signal peptidase. It eliminates the maturation of pro-lipoproteins by inhibition of the enzyme that converts pro-lipoprotein to lipoprotein, acting as a substrate analog of the signal sequence in the outer membrane of Gram-negative bacteria.

General description

Globomycin is a cyclic peptide antibiotic, which inhibits the growth of enteric Gram-negative bacteria through cell wall synthesis inhibition.

antibiotic activity spectrumGram-negative bacteria
assay≥98% (HPLC)
biological sourceStreptomyces hagronensis
colorwhite
formpowder
InChI keyVFGBXFZXJAWPOE-UHFFFAOYSA-N
InChI1S/C32H57N5O9/c1-9-11-12-13-14-24-20(6)32(45)37(8)23(15-18(3)4)29(42)35-26(19(5)10-2)31(44)34-22(17-38)28(41)36-27(21(7)39)30(43)33-16-25(40)46-24/h18-24,26-27,38-39H,9-17H2,1-8H3,(H,33,43)(H,34,44)(H,35,42)(H,36,41)
mode of actionenzyme | inhibits
Quality Level200
solubilityDMSO: 1 mg/mL
storage temp.−20°C
Cas Number67076-74-8
This product has met the following criteria: